scholarly article | Q13442814 |
P50 | author | Anthony Hoang | Q90654296 |
Lambros Stamatakis | Q97527341 | ||
Maria J Merino | Q107749611 | ||
Hayet Amalou | Q114421918 | ||
Annerleim Walton-Diaz | Q114421922 | ||
Srinivas Vourganti | Q114421924 | ||
Mohummad Minhaj Siddiqui | Q37831177 | ||
Soroush Rais-Bahrami | Q40114897 | ||
Bradford J. Wood | Q40114938 | ||
Baris Turkbey | Q88769455 | ||
Jeffrey Nix | Q89071956 | ||
Cheng William Hong | Q89304800 | ||
Peter L Choyke | Q90059714 | ||
Peter A Pinto | Q90059716 | ||
P2093 | author name string | Sheng Xu | |
P2860 | cites work | Screening for prostate cancer | Q24201690 |
MRI of localized prostate cancer: coming of age in the PSA era | Q27002672 | ||
Cancer statistics, 2013 | Q27860762 | ||
Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies | Q30047599 | ||
Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging | Q34021950 | ||
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? | Q34534796 | ||
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer | Q34918676 | ||
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging | Q35202301 | ||
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging | Q35354750 | ||
Documenting the location of prostate biopsies with image fusion | Q35738511 | ||
Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device | Q36579232 | ||
Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy | Q37007165 | ||
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies | Q37149144 | ||
Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen | Q37381526 | ||
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease | Q37807744 | ||
The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety | Q38039328 | ||
Ultrasound guided transrectal core biopsies of the palpably abnormal prostate | Q39278520 | ||
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer | Q39391979 | ||
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer | Q40114843 | ||
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience | Q45133435 | ||
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. | Q45967722 | ||
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? | Q48006856 | ||
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? | Q74591846 | ||
P433 | issue | 3 | |
P304 | page(s) | 234-238 | |
P577 | publication date | 2014-05-01 | |
P1433 | published in | Diagnostic and interventional radiology : official journal of the Turkish Society of Radiology | Q26842393 |
P1476 | title | Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session | |
P478 | volume | 20 |